T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults.
Saved in:
| Title: | T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults. |
|---|---|
| Authors: | Salaun B; GSK, Rue de l'Institut, Rixensart, Belgium., De Smedt J; GSK, Rue de l'Institut, Rixensart, Belgium., Vernhes C; Sanofi, Lyon, France., Moureau A; Sanofi, Lyon, France., Öner D; Biomarkers Infectious Diseases, Janssen Pharmaceutica NV, Beerse, Belgium., Bastian AR; Janssen Vaccines & Prevention B.V., Leiden, Netherlands., Janssens M; GSK, Rue de l'Institut, Rixensart, Belgium., Balla-Jhagjhoorsingh S; Janssen Vaccines & Prevention B.V., Leiden, Netherlands., Aerssens J; Biomarkers Infectious Diseases, Janssen Pharmaceutica NV, Beerse, Belgium., Lambert C; GSK, Rue de l'Institut, Rixensart, Belgium., Coenen S; Centre for General Practice, Department of Family Medicine and Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium., Butler CC; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom., Drysdale SB; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health and care Research (NIHR) Oxford Biomedical Research Centre, Oxford, United Kingdom., Wildenbeest JG; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health and care Research (NIHR) Oxford Biomedical Research Centre, Oxford, United Kingdom., Openshaw PJM; National Heart and Lung Institute , Imperial College London, London, United Kingdom., Bont L; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.; ReSViNET Foundation, Julius Clinical, Zeist, Netherlands. |
| Source: | Frontiers in immunology [Front Immunol] 2023 Oct 13; Vol. 14, pp. 1260146. Date of Electronic Publication: 2023 Oct 13 (Print Publication: 2023). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37936699 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Salaun+B%22">Salaun B</searchLink>; GSK, Rue de l'Institut, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22De+Smedt+J%22">De Smedt J</searchLink>; GSK, Rue de l'Institut, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Vernhes+C%22">Vernhes C</searchLink>; Sanofi, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Moureau+A%22">Moureau A</searchLink>; Sanofi, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Öner+D%22">Öner D</searchLink>; Biomarkers Infectious Diseases, Janssen Pharmaceutica NV, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Bastian+AR%22">Bastian AR</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, Netherlands.<br /><searchLink fieldCode="AU" term="%22Janssens+M%22">Janssens M</searchLink>; GSK, Rue de l'Institut, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Balla-Jhagjhoorsingh+S%22">Balla-Jhagjhoorsingh S</searchLink>; Janssen Vaccines & Prevention B.V., Leiden, Netherlands.<br /><searchLink fieldCode="AU" term="%22Aerssens+J%22">Aerssens J</searchLink>; Biomarkers Infectious Diseases, Janssen Pharmaceutica NV, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Lambert+C%22">Lambert C</searchLink>; GSK, Rue de l'Institut, Rixensart, Belgium.<br /><searchLink fieldCode="AU" term="%22Coenen+S%22">Coenen S</searchLink>; Centre for General Practice, Department of Family Medicine and Population Health (FAMPOP), University of Antwerp, Antwerp, Belgium.; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.<br /><searchLink fieldCode="AU" term="%22Butler+CC%22">Butler CC</searchLink>; Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Drysdale+SB%22">Drysdale SB</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health and care Research (NIHR) Oxford Biomedical Research Centre, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wildenbeest+JG%22">Wildenbeest JG</searchLink>; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Pollard+AJ%22">Pollard AJ</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the National Institute for Health and care Research (NIHR) Oxford Biomedical Research Centre, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Openshaw+PJM%22">Openshaw PJM</searchLink>; National Heart and Lung Institute , Imperial College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bont+L%22">Bont L</searchLink>; Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.; ReSViNET Foundation, Julius Clinical, Zeist, Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2023 Oct 13; Vol. 14, pp. 1260146. <i>Date of Electronic Publication: </i>2023 Oct 13 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37936699 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2023.1260146 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1260146 Titles: – TitleFull: T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Salaun B – PersonEntity: Name: NameFull: De Smedt J – PersonEntity: Name: NameFull: Vernhes C – PersonEntity: Name: NameFull: Moureau A – PersonEntity: Name: NameFull: Öner D – PersonEntity: Name: NameFull: Bastian AR – PersonEntity: Name: NameFull: Janssens M – PersonEntity: Name: NameFull: Balla-Jhagjhoorsingh S – PersonEntity: Name: NameFull: Aerssens J – PersonEntity: Name: NameFull: Lambert C – PersonEntity: Name: NameFull: Coenen S – PersonEntity: Name: NameFull: Butler CC – PersonEntity: Name: NameFull: Drysdale SB – PersonEntity: Name: NameFull: Wildenbeest JG – PersonEntity: Name: NameFull: Pollard AJ – PersonEntity: Name: NameFull: Openshaw PJM – PersonEntity: Name: NameFull: Bont L IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 10 Text: 2023 Oct 13 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 14 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |